Teleflex Incorporated logo

Teleflex IncorporatedNYSE: TFX

Profile

Sector:

Healthcare

Country:

United States

IPO:

17 March 1980

Next earnings report:

21 February 2025

Last dividends:

15 August 2024

Next dividends:

15 November 2024
$8.84 B
-46%vs. 3y high
92%vs. sector
-23%vs. 3y high
66%vs. sector
-55%vs. 3y high
57%vs. sector
-50%vs. 3y high
46%vs. sector

Price

pre-market | 47 min ago
$190.44-$0.34(-0.18%)
$764.38 M$813.33 M
$764.38 M$111.00 M

Analysts recommendations

Institutional Ownership

TFX Latest News

Teleflex to Present at the Jefferies London Healthcare Conference
globenewswire.com07 November 2024 Sentiment: POSITIVE

WAYNE, Pa., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, who is the Chairman, President, and CEO of Teleflex Incorporated (NYSE: TFX), will be speaking at the Jefferies London Healthcare Conference. This event is set to take place on Thursday, November 21, 2024, at 9:30 a.m. (GMT).

Here's Why Teleflex (TFX) is a Strong Growth Stock
zacks.com05 November 2024 Sentiment: POSITIVE

No matter if you focus on value, growth, or momentum investing, the Zacks Style Scores can help you identify strong stocks more easily. This is one of the key benefits of the Zacks Premium research service.

Why Teleflex (TFX) is a Top Value Stock for the Long-Term
zacks.com01 November 2024 Sentiment: POSITIVE

No matter if you invest in value, growth, or momentum, discovering solid stocks is simpler with the Zacks Style Scores, which is a key part of the Zacks Premium research service.

Teleflex Q3 Earnings Top, Stock Falls on Lowered 2024 Revenue Outlook
zacks.com01 November 2024 Sentiment: POSITIVE

In the third quarter of 2024, TFX enjoys advantages from having a varied range of products, particularly in the Vascular Access and Interventional areas.

Teleflex Incorporated (TFX) Q3 2024 Earnings Call Transcript
seekingalpha.com31 October 2024 Sentiment: POSITIVE

Teleflex Incorporated (NYSE:TFX) will hold its Q3 2024 Results Conference Call on October 31, 2024, at 8:00 AM ET. Key company participants include Lawrence Keusch, Liam Kelly, and Thomas Powell, while various analysts from firms like Morgan Stanley and Wells Fargo will also join the call. The operator welcomed everyone and mentioned that the call is being recorded and will be available for replay on the company's website soon.

Teleflex (TFX) Surpasses Q3 Earnings Estimates
zacks.com31 October 2024 Sentiment: POSITIVE

Teleflex (TFX) reported quarterly earnings of $3.49 per share, which is higher than the Zacks Consensus Estimate of $3.38 per share. This is a decrease compared to earnings of $3.64 per share from the same period last year.

Teleflex beats quarterly profit estimates on robust medical devices demand
reuters.com31 October 2024 Sentiment: POSITIVE

On Thursday, Teleflex, a company that makes surgical equipment, announced that its profits for the third quarter were higher than anticipated, thanks to a strong demand for its medical devices.

Teleflex Announces Quarterly Dividend
globenewswire.com31 October 2024 Sentiment: POSITIVE

WAYNE, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) has announced that its Board of Directors has approved a quarterly cash dividend of $0.34 per share of common stock. This dividend will be paid on December 16, 2024, to shareholders who are on record as of the end of business on November 15, 2024.

Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook
globenewswire.com31 October 2024 Sentiment: POSITIVE

WAYNE, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) has released its financial results for the third quarter, which ended on September 29, 2024.

First Patient Enrolled in Teleflex's Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)
globenewswire.com29 October 2024 Sentiment: POSITIVE

This randomized, controlled study will be the first to provide personalized spacing evidence for patients who experience a recurrence of prostate cancer after surgery. It aims to include these specific patients in its research. This study is significant as it focuses on a unique aspect of treatment for prostate cancer.

What type of business is Teleflex Incorporated?

Teleflex Incorporated specializes in designing, developing, and manufacturing disposable medical instruments and devices for general diagnostic and therapeutic procedures, as well as for surgical use. The company's product portfolio includes several product lines with a wide range of solutions: vascular access, interventional products, anesthesia products, surgical instruments... Teleflex develops and manufactures devices and instruments for other medical equipment manufacturers, specifically custom designed extrusions, diagnostic and interventional catheters, balloons and balloon catheters, dilator sets, suture materials, performance fibers, and biodegradable resins and fibers. The company was founded in 1943 and is headquartered in Wayne, Pennsylvania.

What sector is Teleflex Incorporated in?

Teleflex Incorporated is in the Healthcare sector

What industry is Teleflex Incorporated in?

Teleflex Incorporated is in the Medical Instruments & Supplies industry

What country is Teleflex Incorporated from?

Teleflex Incorporated is headquartered in United States

When did Teleflex Incorporated go public?

Teleflex Incorporated initial public offering (IPO) was on 17 March 1980

What is Teleflex Incorporated website?

https://www.teleflex.com

Is Teleflex Incorporated in the S&P 500?

Yes, Teleflex Incorporated is included in the S&P 500 index

Is Teleflex Incorporated in the NASDAQ 100?

No, Teleflex Incorporated is not included in the NASDAQ 100 index

Is Teleflex Incorporated in the Dow Jones?

No, Teleflex Incorporated is not included in the Dow Jones index

When was Teleflex Incorporated the previous earnings report?

No data

When does Teleflex Incorporated earnings report?

The next expected earnings date for Teleflex Incorporated is 21 February 2025